The Priority Review pathway has been developed by the Taiwan Food and Drug Adinistration of Taiwan (Chinese Taipei).

This pathway accelerates the regulatory review process.

It is an abridged review (a reliance pathway).

Priority Review: 240days. Submission → filing meeting (~40 days) → review meeting (~100 days) → notification for completion of review (~130 days) → advisory committee (130~210 days) → approval/non-approval by TFDA (~240 days).